Which is the first-line approach for treating acute dystonia caused by antipsychotics?

Prepare for the ECPI Mental Health Exam 1. Use our flashcards and multiple choice questions for study assistance, with hints and detailed explanations included. Achieve exam success!

Multiple Choice

Which is the first-line approach for treating acute dystonia caused by antipsychotics?

Explanation:
Acute dystonia from antipsychotics stems from an imbalance in the basal ganglia where dopamine blockade increases acetylcholine activity, leading to sudden, painful muscle contractions. The best first-line treatment is an anticholinergic medication such as benztropine or diphenhydramine. These drugs quickly counteract the excess acetylcholine, often providing rapid relief—especially when given by injection for urgent symptoms. This direct approach targets the underlying neurotransmitter mismatch that causes dystonia, making it more effective than alternatives like beta-blockers (which are used for akathisia), stimulants, or SSRIs, which do not address the cholinergic-dopaminergic imbalance. If needed, administer these anticholinergics intramuscularly or intravenously for faster control, with oral forms available for milder cases.

Acute dystonia from antipsychotics stems from an imbalance in the basal ganglia where dopamine blockade increases acetylcholine activity, leading to sudden, painful muscle contractions. The best first-line treatment is an anticholinergic medication such as benztropine or diphenhydramine. These drugs quickly counteract the excess acetylcholine, often providing rapid relief—especially when given by injection for urgent symptoms. This direct approach targets the underlying neurotransmitter mismatch that causes dystonia, making it more effective than alternatives like beta-blockers (which are used for akathisia), stimulants, or SSRIs, which do not address the cholinergic-dopaminergic imbalance. If needed, administer these anticholinergics intramuscularly or intravenously for faster control, with oral forms available for milder cases.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy